Details for New Drug Application (NDA): 019516

✉ Email this page to a colleague

NDA 019516 describes MS CONTIN, which is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from one supplier. Additional details are available on the MS CONTIN profile page.

The generic ingredient in MS CONTIN is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for 019516

Tradename:	MS CONTIN
Applicant:	Purdue Pharma Lp
Ingredient:	morphine sulfate
Patents:	0

Pharmacology for NDA: 019516

Mechanism of Action	Full Opioid Agonists

Medical Subject Heading (MeSH) Categories for 019516

Analgesics, Opioid
Narcotics

Suppliers and Packaging for NDA: 019516

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516	NDA	Rhodes Pharmaceuticals L.P.	42858-515	42858-515-01	100 TABLET in 1 BOTTLE, PLASTIC (42858-515-01)
MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516	NDA	Rhodes Pharmaceuticals L.P.	42858-631	42858-631-01	100 TABLET in 1 BOTTLE, PLASTIC (42858-631-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	30MG
Approval Date:	May 29, 1987	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	60MG
Approval Date:	Apr 8, 1988	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET, EXTENDED RELEASE;ORAL			Strength	15MG
Approval Date:	Sep 12, 1989	TE:	AB	RLD:	Yes

Expired US Patents for NDA 019516

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-005	Nov 8, 1993	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-003	Sep 12, 1989	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-004	Jan 16, 1990	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-002	Apr 8, 1988	4,366,310	⤷ Subscribe
Purdue Pharma Lp	MS CONTIN	morphine sulfate	TABLET, EXTENDED RELEASE;ORAL	019516-001	May 29, 1987	4,366,310	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.